Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-053005
Filing Date
2017-09-15
Accepted
2017-09-15 16:43:47
Documents
1
Period of Report
2017-09-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3833
  Complete submission text file 0001209191-17-053005.txt   5093
Mailing Address
Business Address
PORTER MICHAEL E (Reporting) CIK: 0001108494 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35409 | Film No.: 171088380

Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Issuer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations